Drug Development for Pediatric Populations: Regulatory Aspects
Pediatric aspects are nowadays integrated early in the development process of a new drug. The stronger enforcement to obtain pediatric information by the regulatory agencies in recent years resulted in an increased number of trials in children. Specific guidelines and requirements from, in particula...
Saved in:
Main Authors: | Jochen Zisowsky (Author), Jasper Dingemanse (Author), Andreas Krause (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetic/pharmacodynamic modeling of drug interactions at the P2Y12 receptor between selatogrel and oral P2Y12 antagonists
by: Andrea Henrich, et al.
Published: (2021) -
Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist
by: Andreas Krause, et al.
Published: (2023) -
National seminar on "regulatory and quality aspects of herbal drugs and botanicals"
by: Sayeed Ahmad
Published: (2015) -
Methodological and regulatory aspects of pharmaceutical development of biological products
by: D. V. Kurkin, et al.
Published: (2024) -
Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development
by: Dipak Dilip Gadade, et al.
Published: (2016)